Making the Move from Big Pharma to Biotech: Real Stories of Risks, Rewards, Failures & Successes


Virtual - Zoom  
Tuesday, February 22, 2022 7:00 PM - 8:30 PM   Add to Calendar Eastern Standard Time

Capital is pouring into life sciences at unprecedented amounts with all-time highs being reached in each of the past 8 quarters. Global demand for talent, services, space, equipment and consumables continues to grow exponentially and the FDA is fast tracking approvals like never before. All of these market trends are giving rise to startup scene that is bigger and better than ever. Learn from five experts about what it takes to make the change from Big Pharma to Biotech. Hear the real story about risks, rewards, unexpected failures and unprecedented successes. Moderator: Lisa Pilla, Principal, CoAction Consulting, LLC The Panel: • Jenny Chaplin, VP Strategic Operations, Bellicum Pharmaceuticals • Audrey Greenberg, Co-founder, Center for Breakthrough Medicines • Laura Randa, President and CEO, Toivoa Therapeutics • Stella K. Vnook, CEO, NAKI Therapeutics • Amy Winnen, Vice President, Head Value Access and Policy at Fulcrum Therapeutics

HBA New York and HBA NY/NJ/CT Region present

Making the Move from Big Pharma to Biotech: Real Stories of Risks, Rewards, Failures & Successes


Date and time
Tuesday, 22 February
07:00PM - 08:30PM EST
Location
Virtual - Zoom

Event Contact
Lisa Pilla
+1 (973) 879-4190
Competencies
12. Continues to learn, grow and transform

Capital is pouring into life sciences at unprecedented amounts with all-time highs being reached in each of the past 8 quarters. Global demand for talent, services, space, equipment and consumables continues to grow exponentially and the FDA is fast tracking approvals like never before. All of these market trends are giving rise to startup scene that is bigger and better than ever. Learn from five experts about what it takes to make the change from Big Pharma to Biotech. Hear the real story about risks, rewards, unexpected failures and unprecedented successes.

Moderator: Lisa Pilla, Principal, CoAction Consulting, LLC
The Panel:
• Jenny Chaplin, VP Strategic Operations, Bellicum Pharmaceuticals
• Audrey Greenberg, Co-founder, Center for Breakthrough Medicines
• Laura Randa, President and CEO, Toivoa Therapeutics
• Stella K. Vnook, CEO, NAKI Therapeutics
• Amy Winnen, Vice President, Head Value Access and Policy at Fulcrum Therapeutics


Agenda 
7- 7:10 Introduction
7:10- 7:50 Panel Discussion
7:50-8:20 Q&A
8:20 -8:30 Closing

Registration information
Event is open to: HBA Members and Nonmembers

Featured Speakers

Jenny  Chaplin
Vice President, Strategic Operations
Bellicum Pharmaceuticals, Inc.
Audrey  Greenberg
Co-Founder and Chief Business Officer
Center for Breakthrough Medicines
Lisa  Pilla
Sr. Vice President
CoAction Consulting, LLC
Laura  Randa
CEO and Co-Founder
Toivoa Therapeutics
Amy  Winnen
Vice President, Head Value Access and Policy, Fulcrum Therapeutics
Fulcrum Therapeutics
Learning Objectives
- Learn more about the Biotech Executive World - Benefits, rewards and challenges
- Why executives from big pharma took the leap
- What it takes to lead in the Start-up world

Registration information

The registration button at the bottom of the page will not show if online registration has closed or if the event has reached capacity. If you are a guest and the registration button is not showing, it may be that this is a member-only event. Read more about the benefits of membership or contact us about membership.

The HBA will make reasonable modifications to policies and programs to ensure that people with special needs have an equal opportunity to enjoy all of its programs. Contact us if you require special accommodations for this event.

 Price LevelRegular
Collapse group

Registration: Regular Registration

 Member$10.00
 Member - Euro€8.00
 Non-Member$20.00
 Non-Member - Euro€17.00

By registering for this event, you acknowledge that you may be photographed, videotaped and/or audio-taped during the course of the meeting and hereby give permission for your image, voice, or survey comments to be used in education, training, promotion and/or trade and communications media by the Healthcare Businesswomen's Association in any and all media throughout the world, without restriction as to frequency or duration of usage.